Gene · 7706
Papers2,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,924
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| m5C RNA Methylation Is Dysregulated by Oncogenic Herpesviruses via c-Myc Signaling to Counteract Host Antiviral Factors. | bioRxiv | 2025 | 40654933 | PubTator, text mining | PubMed |
| TRIM25 potentiates innate immune response to Senecavirus A by enhancing K63-linked ubiquitination of RIG-I and K48-linked ubiquitin-facilitated degradation of PFKP. | Vet Microbiol | 2025 | 40651151 | PubTator, text mining | PubMed |
| Erdafitinib inhibits the tumorigenicity of MDA-MB-231 triple-negative breast cancer cells by inducing TRIM25/ubiquitin-dependent degradation of FGFR4. | Breast Cancer Res | 2025 | 40635078 | PubTator, text mining | PubMed |
| Experimental and evolutionary evidence for horizontal transfer of an envelope fusion protein gene between thogotoviruses and baculoviruses. | J Virol | 2025 | 40558095 | PubTator, text mining | PubMed |
| iGTP: learning interpretable cellular embedding for inferring biological mechanisms underlying single-cell transcriptomics. | Brief Bioinform | 2025 | 40551620 | PubTator, text mining | PubMed |
| TRIM25 ubiquitinates and degrades p62/SQSTM1 to suppress autophagy. | Acta Biochim Biophys Sin (Shanghai) | 2025 | 40542578 | Swiss-Prot, curated | PubMed |
| The Role of Pattern Recognition Receptors in Epigenetic and Metabolic Reprogramming: Insights into Trained Immunity. | J Inflamm Res | 2025 | 40535352 | PubTator, text mining | PubMed |
| Correction to "TRIM25 mutation (p.C168*), coding for an E3 ubiquitin ligase, is a cause of early-onset autosomal dominant dementia with amyloid load and Parkinsonism." | Alzheimers Dement | 2025 | 40495571 | PubTator, text mining | PubMed |
| Utilizing Multi-omics analysis to elucidate the role of mitochondrial gene defects in Gastric cancer progression. | PLoS One | 2025 | 40489463 | PubTator, text mining | PubMed |
| The Function of TRIM25 in Antiviral Defense and Viral Immune Evasion. | Viruses | 2025 | 40431746 | PubTator, text mining | PubMed |
| Genome-wide approach to study gene-nutrient intake interactions in type 2 diabetes mellitus in a large Korean cohort. | Front Nutr | 2025 | 40400704 | PubTator, text mining | PubMed |
| Energetics and evolutionary fitness. | Proc Natl Acad Sci U S A | 2025 | 40378014 | PubTator, text mining | PubMed |
| HBV core protein enhances WDR46 stabilization to upregulate NUSAP1 and promote HCC progression. | Hepatol Commun | 2025 | 40366140 | PubTator, text mining | PubMed |
| Apolipoprotein E promotes primary resistance to AR-targeted therapy via inducing TRIM25-mediated AR ubiquitination and sensitizes immunotherapy in prostate cancer. | Theranostics | 2025 | 40365288 | PubTator, text mining | PubMed |
| Discovery and optimisation of a covalent ligand for TRIM25 and its application to targeted protein ubiquitination. | Chem Sci | 2025 | 40365055 | PubTator, text mining | PubMed |
| Bisphenol a Disrupts Steroidogenesis and Induces Apoptosis in Human Granulosa Cells Cultured In Vitro. | Int J Mol Sci | 2025 | 40362320 | PubTator, text mining | PubMed |
| Meisoindigo Acts as a Molecular Glue to Target PKMYT1 for Degradation in Chronic Myeloid Leukemia Therapy. | Adv Sci (Weinh) | 2025 | 40279509 | PubTator, text mining | PubMed |
| TRIM25 facilitates ferroptosis in ovarian cancer through promoting PIEZO1 K63-linked ubiquitination and degradation. | Transl Oncol | 2025 | 40250035 | PubTator, text mining | PubMed |
| Identification of RING E3 pseudoligases in the TRIM protein family. | Nat Commun | 2025 | 40216791 | PubTator, text mining | PubMed |
| Exogenous RNA surveillance by proton-sensing TRIM25. | Science | 2025 | 40179174 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7706/papers?page=8